Precautions - Acelity KCI PREVENA PLUS Mode D'emploi

rash). Silver in the interface layer of the PREVENA PLUS™ Dressing is not intended to treat infection,
but to reduce bacterial colonization in the fabric. If infection develops, PREVENA PLUS™ Therapy
should be discontinued until the infection is treated.
Allergic Response: The PREVENA PLUS™ Dressing has an acrylic adhesive coating and a skin
interface layer with silver, which may present a risk of an adverse reaction in patients who are allergic
or hypersensitive to acrylic adhesives or silver. If a patient has a known allergy or hypersensitivity to
these materials, do not use the PREVENA PLUS™ Dressings. If any signs of allergic reaction, irritation
or hypersensitivity develop, such as redness, swelling, rash, urticaria or significant pruritus, patient
should consult a physician immediately. If bronchospasm or more serious signs of allergic reaction
appear, the patient should turn off the therapy unit and seek immediate emergency medical
assistance.
Defibrillation: Remove the PREVENA PLUS™ Dressing if defibrillation is required in the area of
dressing placement. Failure to remove the dressing may inhibit transmission of electrical energy and/
or patient resuscitation.
Magnetic Resonance Imaging (MRI): All KCI Therapy Units, including the PREVENA PLUS™ 125
Therapy Unit, are MR unsafe. Do not take therapy units into the MR environment. The PREVENA
PLUS™ Dressings can typically remain on the patient with minimal risk in an MR environment.
Interruption of PREVENA PLUS™ Therapy during MRI may reduce the effectiveness of the PREVENA
PLUS™ Incision Management System. The PREVENA PLUS™ Dressings pose no known hazards in an
MR environment with the following conditions of use: static magnetic field of 3 Tesla or less, spatial
gradient field of 720 Gauss/cm or less and maximum whole-body-averaged specific absorption rate
(SAR) of 3W/kg for 15 minutes of scanning.
Diagnostic Imaging: The PREVENA PLUS™ Dressing contains metallic silver that may impair
visualization with certain imaging modalities.
Hyperbaric Oxygen Therapy (HBO): Do not take the PREVENA PLUS™ 125 Therapy Unit, V.A.C.®
Therapy Units or PREVENA PLUS™ Dressings into a hyperbaric oxygen chamber. They are not
designed for this environment and should be considered a fire hazard. If PREVENA PLUS™ Therapy is
reinitiated after HBO treatment, do not readhere the same dressing; a new dressing must be applied.
Canister Full: If at any time while using the PREVENA PLUS™ Incision Management System the
canister becomes full of fluid, indicated by a therapy unit alert or visual inspection, the patient should
turn off the therapy unit and contact the treating physician for additional instruction.
Standard Operation: Do not use accessories or materials not provided with the PREVENA PLUS™
Incision Management System. For a list of acceptable therapy units with which PREVENA PLUS™
Dressings may be used, see the Product Description and Indication for Use section.

PRECAUTIONS

Standard Precautions: To reduce the risk of transmission of bloodborne pathogens, apply standard
precautions for infection control with all patients, per institutional protocol, regardless of their
diagnosis or presumed infection status.
7